Altimmune, Inc. (ALT) Tops Q3 EPS by 6c

Altimmune, Inc. (NASDAQ: ALT) reported Q3 EPS of ($0.39), $0.06 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $362 thousand versus the consensus estimate of $857 million.

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• UBS Reiterates Buy Rating on Darden Restaurants (DRI) Ahead of Q1 Earnings
• Brinker Int'l (EAT) PT Lowered to $240 at DA Davidson Ahead of Analyst Day